Sangbad Voice 9, International Desk: In a remarkable stride within the realm of medical science, Russia has unveiled the development of an mRNA vaccine aimed at combating cancer, with plans to provide it to patients at no expense by the year 2025. This groundbreaking revelation was disclosed by Andrey Kaprin, the General Director of the Radiology Medical Research Center, during an interview with Radio Rossiya.
As reported by the TASS news agency, this innovative vaccine is the culmination of collaborative endeavors among various esteemed research institutions. Preliminary trials have indicated its efficacy in inhibiting tumor proliferation and thwarting metastasis, as articulated by Alexander Gintsburg, the Director of the Gamaleya National Research Center for Epidemiology and Microbiology.
The mechanism of mRNA vaccines involves the introduction of a fragment of messenger RNA into the organism, which incites cells to synthesize a specific protein. Ribonucleic acid, or RNA, is a complex polymer vital for a multitude of biological processes within living organisms.
Upon encountering this protein, the immune system identifies it as an intruder and mobilizes antibodies to combat it. In the context of oncology, this intricate process is meticulously designed to enhance the immune system's capacity to recognize and obliterate malignant cells.
